The SPIREA Study is evaluating an investigational medication for adults with active idiopathic inflammatory myopathies (IIM).
You may be able to participate if you:
Are at least 18 years of age Have active IIM confirmed by a physician (such as a rheumatologist, neurologist, or dermatologist) Are taking standard-of-care medication to treat your active IIM Meet at least 1 of the following criteria at screening:
Have an active rash associated with IIM
Have a muscle biopsy, muscle MRI, or electromyography report from the past 12 weeks that
confirms active IIM
Have any muscle enzyme elevation (this will be tested during the screening period)
Find out if you might be a fit for this study by completing the quick survey below.